For the Inventor, By the Inventor

Enter assignee name

Leuven, Belgium

Life Sciences Research Partners Vzw

USPTO Granted Patents = 41

% Expired Patents = 56.1

CIPO Patents = 6

EPO Patents = 32

Forward Citations = 156

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Peter Carmeliet (14 out of 21 patents)

Jean-Marie Saint-Remy (13 out of 41 patents)

Désiré Collen (7 out of 10 patents)

4. Thierry Vandendriessche (5 out of 19 patents)

5. Pieter De Bleser (5 out of 10 patents)

6. Marc G Jacquemin (5 out of 13 patents)

7. Marinee Chuah (4 out of 14 patents)

8. Diether Lambrechts (3 out of 3 patents)

9. Wim Robberecht (3 out of 3 patents)

10. Jean-Marie Stassen (3 out of 6 patents)

11. Joost Schymkowitz (2 out of 8 patents)

12. Bert Oosthuyse (2 out of 3 patents)

13. Sandro De Falco (1 out of 8 patents)

14. Frederic Rousseau (1 out of 7 patents)

15. Sonja Loges (1 out of 1 patent)

Core Competencies:

Tumor Hypoxia

Liver-specific Elements

Immunogenic Peptides

Cancer Detection

Synthetic Lethality

Monocyte Biomarkers

Anti-angiogenic Therapy

Stem Cell Recruitment

VEGF Treatment

Thrombocytopenia

Prolyl-hydroxylase Inhibitors

Amyotrophic Lateral Sclerosis

41 patents: Sort by Forward Citations

1. 12409236 - Liver-specific nucleic acid regulatory elements and methods and use thereof (2025-09-09),

2. 11814688 - Markers for determining tumor hypoxia (2023-11-14),

3. 11654201 - Liver-specific nucleic acid regulatory elements and methods and use thereof (2023-05-23),

4. 10982196 - Immunotherapy targeting intracellular pathogens (2021-04-20),

5. 10899795 - Modified epitopes for boosting CD4+ T-cell responses (2021-01-26),

6. 10662232 - Immunogenic peptides and their use in immune disorders (2020-05-26),

7. 10633707 - Markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway (2020-04-28),

8. 10617748 - Immunogenic control of tumours and tumour cells (2020-04-14),

9. 10294529 - Microsatellite instability markers in detection of cancer (2019-05-21),

10. 10149914 - Liver-specific nucleic acid regulatory elements and methods and use thereof (2018-12-11),

11. 10106601 - Inhibition of PLGF to treat philadelphia chromosome positive leukemia (2018-10-23),

12. 10076576 - Minimally toxic prodrugs (2018-09-18),

13. 10041126 - Monocyte biomarkers for cancer detection (2018-08-07),

14. 9862777 - Single domain antibodies against SOD1 and their use in medicine (2018-01-09),

15. 9861661 - Elimination of immune responses to viral vectors (2018-01-09),

Company Overview

Life Sciences Research Partners Vzw, based in Leuven, Belgium, specializes in advancing research in the life sciences sector. The organization focuses on critical areas such as nucleic acid regulatory elements, tumor hypoxia markers, and immunotherapy, contributing to the understanding and treatment of various diseases. Their expertise extends to CD4+ T-cell responses, microsatellite instability, and the development of immunogenic peptides, as well as anti-angiogenic therapies and stem cell recruitment strategies, fostering innovation in therapeutic approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

41 Patents

#5 in Leuven

#95 in Belgium

#16,725 in the World

Leuven, Belgium

Life Sciences Research Partners Vzw

Forward Citations = 156

33 inventors:

Peter Carmeliet (14 out of 21 patents)

Jean-Marie Saint-Remy (13 out of 41 patents)

Désiré Collen (7 out of 10 patents)

4. Thierry Vandendriessche (5 out of 19 patents)

5. Pieter De Bleser (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Life Sciences Research Partners Vzw. Retrieved from https://idiyas.com/company/life-sciences-research-partners-vzw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…